Cellnovo Chooses BGM’s ‘No. 1’ Over JNJ For Diabetes Management System
This article was originally published in Clinica
Cellnovo is integrating Roche’s Accu-Chek blood glucose monitoring platform into the latest version of its mobile, all-in-one diabetes management system. The Swiss drug and diagnostics giant’s BGM technology will replace Johnson & Johnson’s LifeScan OneTouch Vita which Cellnovo has been using until now.
Register for our free email digests: